» Authors » Sue Xu

Sue Xu

Explore the profile of Sue Xu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 97
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao X, Tong Z, Sun L, Zhang Q, Du X, Xu S, et al.
Adv Ther . 2023 Feb; 40(4):1899-1912. PMID: 36737594
Background: Angina pectoris (AP) is the initial and the most common manifestation of coronary artery disease (CAD). Therefore, management and control of AP can help prevent further complications associated with...
2.
Deng Y, Zhang N, Zhang Y, Zhong X, Xu S, Qiu H, et al.
Cell Res . 2022 Feb; 32(4):375-382. PMID: 35210606
Monoclonal antibodies represent important weapons in our arsenal to against the COVID-19 pandemic. However, this potential is severely limited by the time-consuming process of developing effective antibodies and the relative...
3.
Xu R, Harrison P, Chen M, Li L, Tsui T, Fung P, et al.
Mol Ther . 2006 Apr; 13(6):1093-100. PMID: 16581302
Cytoglobin (Cygb), a member of the hexacoordinate globin superfamily (hxHb), is expressed in fibroblasts from a broad range of tissues. The physiological functions of hxHb are still unclear, but biochemical...
4.
Xu R, Rahimi M, Ma H, Fung P, Chang C, Xu S, et al.
Med Sci Monit . 2005 Aug; 11(9):BR305-8. PMID: 16127351
Background: The aim of this study is to provide a basis for the design of appropriate protocols for the shipping and storage of rAAV vectors for experimental laboratory studies and...
5.
Sun X, Krissansen G, Fung P, Xu S, Shi J, Man K, et al.
Int J Cancer . 2004 Oct; 113(4):670-7. PMID: 15472906
Liver cancer has a very poor prognosis and lacks effective therapy. We have previously demonstrated that intraportal injection of adeno-associated-viral (AAV) particles that express angiostatin lead to long-term expression of...
6.
Xu R, Cai K, Zheng D, Ma H, Xu S, Fan S
Curr Gene Ther . 2003 Jul; 3(4):341-55. PMID: 12871021
The hepatitis B virus (HBV) infection is a public health problem worldwide, particularly in East Asia. The current therapy of HBV infection is mostly based on chemical agents and cytokines...
7.
Xu R, Sun X, Tse L, Li H, Chan P, Xu S, et al.
Hepatology . 2003 May; 37(6):1451-60. PMID: 12774025
Metastatic liver cancer has a very poor prognosis and lacks effective therapy. Anti-angiogenic therapies, which starve tumors of blood supply, have proven to be effective in preclinical models because tumor...